ENZON PHARMACEUTICALS, INC.

Company

Viskase Holdings, Inc.

Filed

February 12, 2016

Accession Number

0001037389-16-000156

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →